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Abstract
Recent work has shown that much of the missing heritability of complex traits can be resolved by estimates of heritability
explained by all genotyped SNPs. However, it is currently unknown how much heritability is missing due to poor tagging or
additional causal variants at known GWAS loci. Here, we use variance components to quantify the heritability explained by
all SNPs at known GWAS loci in nine diseases from WTCCC1 and WTCCC2. After accounting for expectation, we observed all
SNPs at known GWAS loci to explain 1:29| more heritability than GWAS-associated SNPs on average (P~3:3|10{5). For
some diseases, this increase was individually significant: 2:07| for Multiple Sclerosis (MS) (P~6:5|10{9) and 1:48| for
Crohn’s Disease (CD) (P~1:3|10{3); all analyses of autoimmune diseases excluded the well-studied MHC region.
Additionally, we found that GWAS loci from other related traits also explained significant heritability. The union of all
autoimmune disease loci explained 7:15| more MS heritability than known MS SNPs (Pv1:0|10{16) and 2:20| more CD
heritability than known CD SNPs (P~6:1|10{9), with an analogous increase for all autoimmune diseases analyzed. We also
observed significant increases in an analysis of w20,000 Rheumatoid Arthritis (RA) samples typed on ImmunoChip, with
2:37| more heritability from all SNPs at GWAS loci (P~2:3|10{6) and 5:33| more heritability from all autoimmune
disease loci (Pv1|10{16) compared to known RA SNPs (including those identified in this cohort). Our methods adjust for
LD between SNPs, which can bias standard estimates of heritability from SNPs even if all causal variants are typed. By
comparing adjusted estimates, we hypothesize that the genome-wide distribution of causal variants is enriched for low-
frequency alleles, but that causal variants at known GWAS loci are skewed towards common alleles. These findings have
important ramifications for fine-mapping study design and our understanding of complex disease architecture.
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Introduction
While association studies have been successful in finding a large
number of significant variants for many complex traits, they have
individually explained relatively little of the total heritability,
motivating analyses that seek to identify this so-called ‘‘missing’’
heritability [1–3]. One hypothesis is that additional causal
variation is present at the known GWAS loci but not fully
quantified by individual GWAS markers [1,2,4–7]. This scenario
may arise if the true causal variant is poorly tagged by any single
GWAS marker [8] or if multiple independent causal variants exist
at the locus [9]. In this case, the variance explained by the most-
significant marker would only provide a lower bound on the local
contribution, and some of the ‘‘missing’’ heritability would in fact
be hidden at the previously discovered loci. If we consider ‘‘local’’
heritability to be the measure of aggregate variance from all causal
variants at a locus, its quantification is an important step towards
fully understanding the contributions made by association studies.
Moreover, estimating components of local heritability indirectly
from the vast amount of GWAS-level data already available would
enrich our current understanding of complex disease architecture
and provide insights into further study-design for post-GWAS fine-
mapping studies. Here, we investigate methods for inferring
components of local heritability at previously identified GWAS loci.
As study sample sizes continue to grow, researchers have
focused on quantifying the amount of heritability explained by
individually significant single-marker associations [4,10–14]. In
well-powered GWAS, one can also look for secondary variants
that are conditionally independent of the leading SNP and
estimate the joint contribution to phenotype. This conditional
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analysis has recently proven effective in GWAS for height [4,15,16]
and multiple case-control traits [17], where a handful of loci were
found to contain independent secondary associations. This strategy
inherently focuses on a small number of independent markers and
the outcome strongly depends on power to detect the primary
association as well as any secondary variants. Such complexities
make it difficult to compare this estimate across different studies and
disease architectures. With additional resources, one can fine-map
implicated loci using denser genotyping or sequencing platforms
and look for more strongly significant markers. Recent studies
involving re-sequencing around known GWAS-associated regions
have identified additional variants explaining significant heritability
in several complex traits [5,18–20]. Looking beyond individual
traits, a fine-mapping study of Celiac disease examined loci
associated with other autoimmune diseases and nearly doubled
the number of significant associations [21]. This approach can
leverage the shared genetic architecture observed in some groups of
related traits [22–24]. Still, such studies have not always yielded
significant associations; a targeted re-sequencing analysis of Type 2
Diabetes did not yield any additional variants beyond what was
known from GWAS [25] and recent work with dense genotyping
did not uncover significant additional heritability at known loci for
Type 2 Diabetes and Coronary Artery Disease [20]. Overall, these
findings motivate methods that can infer components of additional
local heritability using available GWAS data to guide fine-mapping
analysis for identifying additional risk variants.
We propose to address this challenge by making use of all
observed markers in a variance-component analysis, which
optimizes a single measure of effect-size over a sample relatedness
matrix. When sample relatedness is computed directly from the
observed markers - referred to as the genetic relatedness matrix
(GRM) - this variance-component can be used to infer the narrow-
sense heritability explained by these markers. This measurement of
narrow-sense heritability represents the aggregate effect of all causal
variants observed or tagged in the data assuming additive, normally-
distributed effect sizes. Recent work in variance-components
analysis has shown that the contribution of all genotyped SNPs
and any markers in LD with them, denoted h2g, can be estimated
directly from large-sample GWAS data in this way [26–29].
Similarly, our aim is to apply the variance-component model
locally, by constructing the GRM from all typed SNPs at known
GWAS regions and estimating the corresponding local h2g. The
excess of this quantity over the variance explained by known
associations provides a lower bound on additional heritability at the
locus. Uniquely, this method allows the analysis of loci that have no
known association in the focal trait but have been associated with
other related traits, quantifying sources of missing heritability
implicated by shared disease architecture.
In this study, we apply these methods to both simulated and real
phenotypes. Using simulations involving real genotypes, we find
that LD between typed markers can significantly bias the h2g
estimate and propose a correction to the GRM calculation, which
we compare to a recently proposed approach [30]. In local
analysis, we observe higher estimates of heritability with the
adjusted variance-component strategy compared to traditional
association and conditional analysis, particularly when the locus
harbors multiple causal variants. Importantly, our LD residual
correction ensures these statistics are not inflated under the range
of disease architectures considered (unlike the correction of [30]).
We estimate local h2g at known loci for nine common diseases
finding a significant average increase vs. the variance explained by
known associations, with individually significant increases for three
of the traits. We also estimate local heritability at loci identified
only in other related traits, showing significant enrichment in
autoimmune disease for within-trait heritability at cross-trait loci.
For RA, we analyze dense genotypes fromw20,000 samples typed
on the ImmunoChip data as part of the Rheumatoid Arthritis
Consortium International (RACI). This significantly larger sam-
ple-size and deep genotyping empowers us to provide precise
estimates on the significant increases in local heritability within RA
and across non-RA autoimmune traits. Our results have important
implications for fine-mapping study-design as well as the broader
understanding of disease architecture and allelic heterogeneity.
Results
Overview of methods
Our fundamental goal is to explain as much of the local
heritability as possible without upward bias. We consider four
different estimators with unique individual properties: h2GWAS, the
variance explained by the single most associated SNP at a locus,
computed directly from the effect-size of a univariate regression;
h2GWAS, joint, the variance explained by a conditional linear model of
significant SNPs constructed by step-wise regression over all SNPs
in the locus as described by [15–17]; h2g, the heritability inferred
with a standard variance-component constructed from all SNPs in
the locus; and h2gLD, the heritability inferred with an LD-residual
adjusted variance-component constructed from all SNPs in the
locus. The LD adjustment is crucial in scenarios where LD patterns
that are systematically different at causal variants can distort the
observed sample relatedness and bias traditional estimates of h2g, as
previously demonstrated by [30]. Our proposed correction uses
linear regression to transform each SNP into an ‘‘LD residual’’ of
any correlated preceding markers and construct the GRM from
these residuals. We compare this correction to LDAK, the re-
weighing solution of [30], as well as other strategies (see Methods).
Simulations using WTCCC genotype data
Impact of LD on genome-wide estimates of h2g. To be
confident that our conclusions on excess local heritability are
Author Summary
Heritable diseases have an unknown underlying ‘‘genetic
architecture’’ that defines the distribution of effect-sizes
for disease-causing mutations. Understanding this genetic
architecture is an important first step in designing disease-
mapping studies, and many theories have been developed
on the nature of this distribution. Here, we evaluate the
hypothesis that additional heritable variation lies at
previously known associated loci but is not fully explained
by the single most associated marker. We develop
methods based on variance-components analysis to
quantify this type of ‘‘local’’ heritability, demonstrating
that standard strategies can be falsely inflated or deflated
due to correlation between neighboring markers and
propose a robust adjustment. In analysis of nine common
diseases we find a significant average increase of local
heritability, consistent with multiple common causal
variants at an average locus. Intriguingly, for autoimmune
diseases we also observe significant local heritability in loci
not associated with the specific disease but with other
autoimmune diseases, implying a highly correlated under-
lying disease architecture. These findings have important
implications to the design of future studies and our
general understanding of common disease.
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accurate, we first seek to get approximately unbiased estimates for
genome-wide h2g in simulations with realistic genetic architectures.
Using the WTCCC1:CAD cohort (see Table S1), we sampled
5,000 of the genotyped SNPs to be causal variants such that a
fraction f of the markers is low-frequency (0:01vMAFv0:05)
and generate a quantitative trait for which these markers
explained 0.8 of the variance. We stress that in all instances the
causal variants were always present in the GRM and that an
unbiased h2g should equal the induced h
2 of 0.80. We then
estimated the genome-wide heritability from genotyped or
imputed SNPs using the standard GRM as well as four LD-
adjustment strategies (see: Methods) over a range of f from 0 to 1
(Figure S1, Table S2). We find that the standard estimate can be
significantly biased in both directions depending on the disease
architecture and typed markers (Table S2). For genotyped
markers, the standard estimate tends to be inflated when causal
variants are primarily common, and sharply deflated when the
causal variants are primarily uncommon, dropping to as low as
0.50. This is likely caused by the fact that uncommon SNPs
generally to have fewer other markers in high-LD and therefore
become underrepresented in the GRM, deflating their contribu-
tion to heritability. With imputed markers, on the other hand, the
standard estimate exhibits consistent deflation across all low-
frequency variant cut-offs, dropping to 0.55 when all causal
variants are uncommon. Examining the LD-correction schemes,
we see that the LD-pruning strategy eliminates most of the bias but
also reduces the measurement by roughly 25% due to the removal
of correlated markers that offer some independent contribution to
phenotype. The three non-pruning methods perform roughly
similarly, all removing most of the bias without suffering from the
deflation of LD-pruning. For genotyped SNPs, the regression-
based LD residual had a slightly lower error (Table S4), while the
LD shrink based on pairwise correlation resulted in highest error;
with LDAK falling in the middle. For imputed SNPs, LDAK
continuously outperforms the other methods, with LD residuals
exhibiting a slight downwards bias. Since all three methods have
multiple parameters it is likely that these differences are largely due
to proper parameter tuning. However, one key advantage of the
LD residual technique is that it does not exhibit statistically
significant inflation under any disease architecture or platform
tested, while both LDAK and the LD shrink can yield statistically
significant upward bias in both genotyped and imputed SNPs (by
z-test from mean and observed standard error over multiple
simulations, after correcting for 11 tested frequency bins (Table
S2, Figure S1). Likewise, the LD residual also yields a more
conservative estimate of the standard error which, unlike the other
methods, is never lower than the observed standard deviation of
the estimate over all the simulated architectures (Figures S2). This
conservative behavior is particularly important for our aim of
placing an accurate lower bound on components of heritability.
To confirm that this deflation is caused by LD and not the allele
frequency distribution, we permuted the carrier status of each
marker and performed the above experiment again. This
permutation procedure effectively removes any LD and results
in independent genotypes as if sampled from the observed allele
frequency spectrum. As shown in Figure S6, the inferred h2g was
never significantly different from the truth across all disease
models. We note that when causal variants are sampled randomly
from all typed SNPs the standard h2g estimate is approximately
unbiased and confirmed this in our simulations; in this scenario,
the h2gLD estimate exhibited a slight downward bias (95% of the
true h2 on average; Table S3), consistent with our previous
findings that the estimate is conservative.
Performance of methods for local estimation of
heritability. Having established a method for well-controlled
estimates. We use real genotypes from the 7,923 WTCCC2-UC
samples typed at 447,945 SNPs after QC (see Methods, Table S1)
to simulate phenotypes from a range of disease architectures with
each locus centered around 1–10 causal variants sampled from
common or low frequency alleles (MAFw0:10 and MAFv0:05
respectively) and normalized SNP effect-sizes drawn from the
standard normal such that each SNP explains equal phenotypic
variance in expectation (other distributions were also considered,
see Methods). The simulated disease architecture mimics a large-
scale GWAS and consists of 180 loci explaining a total trait
heritability of 0.1, the number and h2GWAS of loci recently
identified in height [4] (see Methods). To quantify the upper-
bound on heritability that can be explained with each method we
first analyze simulated traits where all causal variants have been
typed and are present in the set of analyzed SNPs. Table 1A,B
shows the fraction of total heritability inferred from these
simulations. For the standard unadjusted estimate local h2g, we
see severe deflation with a single low-frequency causal variant
(61% of the true heritability) and slight but statistically significant
inflation with a single common causal variant (108% of the true
heritability), with similar results for multiple causal variants. On
the other hand, the adjusted estimates (h2gLD) from these same
simulated phenotypes are slightly conservative (down to 88% of
the true heritability) but never exhibit severe deflation or
significant inflation and, importantly, are consistent across all trait
architectures. The consistently conservative behavior (avoiding
upward bias in h2gLD) of our LD adjustment approach in extensive
simulations that we conducted is a particularly attractive feature
for our analysis as it ensures robust lower-bounds (modulo
standard error) in real data regardless of disease architecture.
Next, we consider these methods in the realistic scenario where
causal variants are untyped, by removing the causal variant(s) from
the set of SNPs analyzed. Our benchmark is h2GWAS, the variance
explained by the single best tagging marker (see Methods).
Table 1C,D shows that h2g and h
2
gLD have relative results consistent
with those observed over typed causal variants with a lower overall
mean due to incomplete tagging. On the other hand, while the
h2GWAS is roughly equal to h
2
gLD when one variant is causal, h
2
GWAS
(unlike h2gLD) decreases greatly as the number of causal variants
grows. As with the previous simulation, this decrease is not directly
proportional to the number of causals because the GWAS SNP is
always selected as the SNP with highest effect. The h2gLD metric is
always greater than or equal to h2GWAS, with as much as a 2:55|
increase in variance explained when ten common causal variants
are present. As before, we observe that the unadjusted h2g can be
higher than h2gLD when causal variants are common. Since we
generally do not know the underlying disease architecture and
wish to avoid any upward bias, we prefer to use h2gLD. We also
compare to the joint regression-based analysis and observe that
while it can increase explained variance by as much as 1:25| (in
the ten low frequency causal variants scenario) it consistently
recovers less of the true heritability than the variance component
approach.
Analogous simulations over WTCCC1 data drawing causal
variants from genotyped or imputed SNPs over several different
disease architectures (including fewer loci and different effect-sizes)
exhibited the same patterns (see Methods, Table S5,S6,S7,S8,S9).
We also evaluated the impact of including imputed SNPs in the
local heritability analysis, and found that while the absolute
Missing Heritability at GWAS Loci
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estimate increases (particularly for rare variants) the additional
heritability recovered by h2gLD beyond h
2
GWAS is lower, with the
former exhibiting increased variance due to the substantially higher
number of SNPs (Table S10,S11). Unlike our genome-wide
estimates, no significant difference between LDAK and the LD-
residual adjustment was observed in the local analysis (after
accounting for five disease architectures tested) due to generally
increased variance. Given the sporadic upward bias in LDAK in the
genome-wide simulations, we focus on the LD-residual adjustment in
real data but present results from both methods in the supplements.
Although our primary goal is to obtain the highest mean
estimate without upward bias, we also examine the power to detect
a statistically significant increase in local h2gLD versus h
2
GWAS.
Specifically, we use the analytical standard error of the inferred
h2gLD in each of the simulations scenarios from Table 1 to report
the fraction of 100 random simulations where h2gLD is significantly
higher than h2GWAS (Pv0:05; see Methods). This power compu-
tation strongly depends on the sample-size, total h2g, disease
architecture and average relatedness of the samples, and may
therefore vary across different datasets. In Table S12, we observe
that the power to detect a statistically significant increase in h2gLD
versus h2GWAS is highly variable, ranging from below 10% for the 1
and 2 causal variant models to as high as 56% for the 10 causal
Table 1. Fraction of simulated local heritability explained in WTCCC2 genotypes.
# Low-frequency typed causals:
A: 1 2 3 5 10
h2GWAS 100% 82% 69% 55% 37%
h2GWAS, joint 100% 85% 74% 59% 44%
h2g local seð Þ 61% (1%) 65% (1%) 61% (1%) 58% (2%) 60% (1%)
h2g LDlocal seð Þ 94% (2%) 92% (2%) 97% (3%) 95% (2%) 90% (2%)
h2gLD
.
h2GWAS
0.94 1.13 1.40 1.71 2.37
# Common typed causals:
B: 1 2 3 5 10
h2GWAS 100% 81% 69% 56% 38%
h2GWAS, joint 101% 84% 73% 60% 43%
h2g local seð Þ 108% (1%) 102% (2%) 109% (1%) 106% (1%) 104% (1%)
h2g LDlocal seð Þ 88% (3%) 92% (3%) 90% (3%) 89% (2%) 89% (3%)
h2gLD
.
h2GWAS
0.88 1.13 1.30 1.60 2.35
# Low-frequency untyped causals:
C: 1 2 3 5 10
h2GWAS 60% 55% 44% 37% 24%
h2GWAS, joint 61% 57% 48% 41% 30%
h2g local seð Þ 47% (1%) 48% (1%) 44% (1%) 39% (1%) 34% (1%)
h2g LDlocal seð Þ 63% (2%) 64% (2%) 67% (3%) 67% (2%) 54% (2%)
h2gLD
.
h2GWAS
1.06 1.17 1.50 1.80 2.24
# Common untyped causals:
D: 1 2 3 5 10
h2GWAS 82% 66% 58% 45% 31%
h2GWAS, joint 83% 69% 61% 50% 36%
h2g local seð Þ 98% (1%) 92% (2%) 99% (1%) 95% (1%) 93% (1%)
h2g LDlocal seð Þ 81% (3%) 83% (3%) 83% (3%) 81% (3%) 81% (3%)
h2gLD
.
h2GWAS
0.99 1.27 1.44 1.76 2.55
Analysis of simulated disease architecture with 180 causal 1Mbp loci yielding a true h2~0:1. In each locus, 1–10 causal variants were sampled from either low-frequency
(0:01vMAFv0:05) of common (MAFw0:10) WTCCC2 SNPs. For each of four methods tested, the fraction of local heritability identified by the method is reported over
50 simulations (with standard error in parenthesis). Top two panels correspond to experiments with observed causal variants and bottom two panels to experiments
with causal variants hidden. In A and B only (where causals are typed), bold-faced h2g and h
2
gLD represents significant difference from 100% by z-score at Pv0:05=5
(accounting for 5 architectures tested). The ratio of h2gLD to h
2
GWAS is reported in the bottom row of each panel (with bold-face indicating significance by t-test at
Pv0:05=5).
doi:10.1371/journal.pgen.1003993.t001
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variant model. When we perform the same analysis in all 15,000
WTCCC1 samples (Table S13) we see that the power is very high,
averaging 47% and reaching nearly 100% for the three causal
variant architecture. These findings indicate that in very large
studies our approach can conclusively identify additional local
heritability.
These simulations demonstrate the value of the variance-
component approach in recovering true additional heritability
beyond that explained by individually or jointly significant
markers, especially in the presence of multiple causal variants.
The same simulations were also performed on the ImmunoChip
genotypes, with similar trends described in more detail below.
Genome-wide heritability analysis of WTCCC case-control
traits
We first analyze the genome-wide heritability explained by
genotyped SNPs in the nine WTCCC1 and WTCCC2 traits
(Table S1). Figure 1 shows the results of this analysis for
unadjusted and LD-adjusted estimates performed over genotyped
and genotyped+imputed SNPs (2.1 million 1000 Genomes [31]
SNPs on average; see Table S1) separately. Results are shown on
the observed scale. (Results on the liability scale are provided in
Figure S4; all numerical values are provided in Table S14,S15.)
We note that stringent quality-control is imperative for heritability
analysis, where many small artifacts can compound into significant
inflation of the genome-wide estimate [23]; this effect can be
exacerbated by LD-adjustment methods, which will tend to
promote low frequency variants that may be especially prone to
QC issues. As in other studies [23,30], we use a series of highly
conservative QC filters to stem this problem, at the cost of filtering
out many potentially informative markers (see Methods). The
absence of any significant false heritability between the two control
cohorts, particularly after LD-adjustment, indicates that genotyping
artifacts are unlikely to be substantial (Figure 1). We note that in the
presence of strong artifacts [30], propose an elegant solution of
estimating SNP weighing scores from an independent population,
and a similar strategy can be applied to the LD-residual adjustment.
For all traits we see that the LD-adjusted estimate from typed
SNPs is higher than the corresponding unadjusted estimate, with
an average of 1:30| for genotyped SNPs. Previous work has
shown the standard estimate to be robust when the trait is
infinitesimal, i.e. where all SNPs are causal with normally
distributed effect-sizes [32,33]. However, as demonstrated in our
simulations and in [30], non-infinitesimal traits with systematically
less LD between rare and low-frequency variants will under-
represent those variants in the un-adjusted kinship, resulting in
deflated h2g estimates when a majority of the causal variants are
low-frequency (Figure S1). The increase in adjusted estimates on
real data therefore implies a genome-wide genetic architecture for
these traits that is generally shifted towards low-frequency variants.
As in our simulations, the effect of LD-adjustment is even stronger
when imputed SNPs are included (2:24| more on average,
comparing dark-green to light-green bars), demonstrating the
downwards bias introduced by an abundance of imputed markers
without LD adjustment. Indeed, without adjustment, all of the
traits exhibit lower h2g after imputation. Interestingly, even though
imputation increases the total number of markers by 15|, the
adjusted estimate from imputed SNPs is, on average, only 1:04|
higher than the corresponding estimate from genotyped SNPs.
Because the LD adjustment effectively removes any new SNP that
is a linear combination of nearby SNPs, this would be consistent
with imputation providing information similar to such linear
combinations [34]. This is further supported by the fact that the
sum of LD-adjusted SNP variances (roughly corresponding to the
independent number of SNPs) for imputed SNPs was only 1:5|
higher than that of typed SNPs. These findings do not minimize
Figure 1. Heritability of genome-wide SNPs for nine complex traits. Components of heritability for typed markers (blue) over nine traits and
imputed markers (green) over seven WTCCC1 traits shown. Light bars correspond to estimates from the standard variance-component and dark bars
correspond to estimate from LD-adjusted variance-component. Two control sub-groups (NBS and 58C) tested against each other as negative control;
diseases tested are Bipolar Disorder (BD), Coronary Artery Disease (CAD), Crohn’s Disease (CD), Hypertension (HT), Rheumatoid Arthritis (RA), Type 1
Diabetes (T1D), Type 2 Diabetes (T2D), Multiple Sclerosis (MS), Ulcerative Colitis (UC). Autoimmune traits (CD, RA, T1D, UC, and MS) excluded the well-
studied MHC region. All traits exhibit an increase after LD adjustment, indicative of a genetic architecture that is shifted towards low-frequency causal
variants. Error bars show analytical standard error of estimate.
doi:10.1371/journal.pgen.1003993.g001
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the utility of imputation for mapping, where individual effect sizes
are important, but does imply that imputed variants are not
explaining dramatically more missing heritability. Based on these
findings and our previous simulations with imputed variants, we
restrict our subsequent variance-components analysis to the
genotyped data only.
Local heritability analysis of WTCCC traits at known
GWAS loci
Next, we infer the amount of local h2gLD around the GWAS loci
for the nine traits and compare to the corresponding h2GWAS and
h2GWAS,joint values (Figure 2, Table S16). When computing the
increase in h2gLD (and its statistical significance), we always account
for h2GWAS and the local expectation, i.e. the increase that would be
expected by chance based on the total genome-wide h2g and the
fraction of genome covered by the variance-component (see
Methods). Across all the nine traits we find a consistent excess of
local heritability, with an average increase of 1:29| over the local
expectation (combined P~3:3|10{5). These results were consis-
tent with the LDAK-based adjustment, which had a mean increase
of 1:34| (Table S18). P-values were computed using a z-test and
consistent to different definitions of h2null (see Methods), but an
analysis involving a comparison to random regions of the genome
also produced similar results (see Methods, Table S17, Figure S5).
Three of these traits (CD, UC, and MS) show individually
significant increases (P~1:3|10{3; P~3:8|10{3; and
P~6:5|10{9 respectively). The regression-based analysis of
jointly significant markers (h2GWAS,joint) yields an average of
1:17| more heritability than h2GWAS. In instances where there
are multiple known associations at a locus, only the leading SNP is
included in h2GWAS but all of the known associated SNPs are
automatically included in h2GWAS,joint, demonstrating that previously
known locus heterogeneity still does not explain as much heritability
as the h2gLD estimate. On average, these loci are explaining 11% of
the genome-wide h2gLD with 1.1% of the genome. Interestingly, the
h2g estimate with no LD-adjustment also yields increased local
heritability for all phenotypes with an even higher average increase
(Table S18). Given that our simulations show an increase in
unadjusted estimates only when the underlying causal variant is
common (Table 1), this increase in real data suggests that most
causal variation in these GWAS loci originates from common causal
variants (in contrast to the rest of the genome; see above).
The presence of significant additional heritability in individual
traits raises the question of whether it is coming from a single
poorly-tagged causal variant or multiple independent causal
variants. In our previous simulations, an increase in local
heritability is not expected under the single causal-variant model
and the ratio of h2gLD to h
2
GWAS has a direct relationship to the
number of causal variants. For the WTCCC2 data, a single rare or
common untyped causal variant is expected to yield an
h2gLD=h
2
GWAS of 1:06| and 0:99|, respectively (Table 1 C,D).
Both are lower than our observed average of 1:29| in real data,
and much lower than significant increases of 1:68| and 2:07| in
UC and MS (Table S16). These results are therefore unlikely to
arise simply due to all loci harboring a single poorly-tagged causal
variant, with the point estimate of 1.29 indicating a likely
architecture of 2–3 causal variants at the average locus. However,
we caution that the variance of this ratio observed in simulations is
very high (for example, 18% of the single common causal
simulations have a local increase greater than 1.29), making it
difficult to reject the single-causal variant hypothesis at this
sample-size. From our previous power estimates (Table S13), we
observe that at a sample-size of 15,000 power to detect multiple
causal variants approaches 100%, allowing us to distinguish
between these two scenarios.
Figure 2. Local heritability around known GWAS loci. Components of heritability inferred at previously known GWAS loci. h2GWAS computed
from leading SNP effect-size; h2GWAS,joint computed from joint model of all known and significant SNPs in region; local expectation computed from
h2GWAS and fraction of genome analyzed; and h
2
gLD computed from LD adjusted variance component over all loci. (*) indicates statistically significant
increase over expectation after accounting for nine tests. Error bars show analytical standard error of estimate. Autoimmune traits (CD, RA, T1D, UC,
and MS) excluded the well-studied MHC region.
doi:10.1371/journal.pgen.1003993.g002
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We note that some of the GWAS loci we analyzed were
genome-wide significant in the WTCCC data and could
potentially exhibit inflated effect-sizes due to winner’s curse if
discovered in this cohort. However, because the heritability from
variance-components and GWAS SNPs are inferred in the same
data, we expect any effect-size inflation to impact both estimates
equally, making our relative comparisons robust even in the
presence of biases. In light of this and the small fraction of such
loci actually present (8% averaged over the 7 WTCCC1 traits) we
do not believe winner’s curse to have had an impact on these
results.
Local heritability analysis of WTCCC traits at GWAS loci
associated to related traits
Recent analyses of multiple phenotypes have demonstrated
significant correlations in genetic architecture for certain groups of
related traits [23,24,35,36]. Unique to the local variance-
components approach, we can also compute components of
heritability at known GWAS loci from multiple related traits
without having genotypes for those traits. This measure provides
an estimate of the additional variation that would be explained by
fine-mapping loci associated with one trait within the affected
samples of another; for example, analyzing known Ulcerative
Colitis loci in a study of Crohn’s Disease. We expect this to be
informative when the traits have correlated genetic architectures,
with causal variants that only reached statistical significance in one
trait potentially explaining heritability in the other. One example
of such related traits is the class of autoimmune disorders, which
are known to have a shared disease architecture as well as many
instances of overlapping GWAS loci [22,37–40]. For each of the
nine traits, we consider the amount of heritability explained by loci
that were previously associated to one or more other autoimmune
diseases but not to the focal trait. By definition, the h2GWAS for
these loci is zero, and so we compare to the local expectation, i.e.
what would be expected by chance from the genome-wide h2gLD
and locus size (see Methods). As with all other analyses, we
specifically exclude the MHC for all autoimmune diseases so as to
investigate the patterns of shared heritability outside of this well-
studied region.
Figure 3 (numerical results in Table S19,S20) shows the results
of this analysis, as well as the increase in heritability explained
compared to the local expectation. The five autoimmune traits
have the highest relative increases and are unique in being
statistically significant. On average, the loci in the autoimmune
traits explain 6:78| more heritability than the local expectation
(combined P~5:0|10{15), compared to 1:02| more for the
non-autoimmune traits (combined P~0:44). Both results were
consistent with the LDAK-adjusted estimate of 7:87| and 0:98|
respectively (Table S20). We again confirmed all significant z-test
results using an empirical expectation by sampling random regions
of the genome (see Methods, Table S17, Figure S5). Importantly,
these results were not substantially different after accounting for
increased heritability in coding regions, with the average increase
after correction still significant at 6:43| (see Methods, Table S21).
We stress that these estimates specifically exclude any known loci
for the respective disease; for example, the results from RA
represent analysis of known autoimmune disease loci not identified
in RA, and likewise for all of the other traits. As such, the
additional heritability we identify would not have been found in a
traditional targeted fine-mapping study that focuses only on trait-
specific loci. Combining these results with the trait-specific
analysis, we observe an average of 3:78| more h2gLD than
h2GWAS at the union of autoimmune and disease-specific loci,
individually significant across all the autoimmune traits (Table
S22). On average, these loci are explaining 27% of the genome-
wide h2gLD. Most significant are the increases for MS and CD, with
Figure 3. Heritability of known autoimmune disease loci. Components of heritability inferred at previously known autoimmune trait loci not
identified for focal trait. Local expectation computed based on fraction of genome analyzed. (*) indicates statistically significant increase over
expectation after accounting for nine tests, respectively. Error bars show analytical standard error of estimate. All analyzed autoimmune traits
(Crohn’s Disease, Rheumatoid Arthritis, Type 1 Diabetes, Multiple Sclerosis, and Ulcerative Colitis) all exhibit significant increase in local h2gLD where
non-autoimmune traits (Bipolar Disorder, Coronary Artery Disease, Hypertension, Type 2 Diabetes) exhibit no significant increase. Autoimmune traits
excluded the well-studied MHC region.
doi:10.1371/journal.pgen.1003993.g003
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7:15| (Pv1:0|10{16) and 2:20| (P~6:1|10{9) more local
h2gLD, respectively.
Overall, we find that the class of autoimmune traits has a shared
genetic architecture at known GWAS loci that can be leveraged to
explain significant additional heritability. Loci found in one
autoimmune trait are expected to harbor significantly more h2gLD
for other traits (beyond what is expected from lying near coding
regions) and can therefore be important targets for fine-mapping
analysis.
Heritability analysis of Rheumatoid Arthritis in
ImmunoChip cohort
We estimate components of local heritability for Rheumatoid
Arthritis in 23,092 samples of European origin typed on the
ImmunoChip platform, recently analyzed for association by Eyre
et al. [41]. The increased SNP density of this data is expected to
provide higher power for local heritability analyses, and we again
compare h2GWAS, h
2
GWAS,joint, h
2
g, and h
2
gLD using simulated
phenotypes from ImmunoChip genotypes (see Methods). We
again observe an inflated h2g and un-inflated h
2
gLD, though the
latter is more conservative than in previous simulations (Table
S23). Overall, the higher density ImmunoChip results in a greater
expected increase when considering all SNPs, particularly when
variants are low-frequency.
We now consider real RA phenotypes. Of the 13 RA GWAS
loci analyzed in the WTCCC1 data, 10 are also present on the
ImmunoChip and we re-estimate local h2gLD at this subset of 10
loci in both studies for comparison (Table 2A). The ImmunoChip
data exhibits an increase in additional heritability explained over
local expectation of 2:16| (P~9:9|10{6), compared to 1:22|
(non-significant at P~0:32) in the corresponding WTCCC1 loci.
The ImmunoChip also exhibits a significant increase in heritability
explained compared to h2GWAS,joint and local expectation, with an
increase of 1:27| (P~3:3|10{3). The ImmunoChip also
contains 17 of the 24 non-RA autoimmune disease loci, also
allowing us to perform the analysis of non-RA autoimmune loci.
Again, we observe the local heritability to increase between the
WTCCC1 and ImmunoChip data from 0.012 to 0.018, with the
latter resulting in an increase of 18:88| compared to local
expectation (P~1:1|10{16, Table 2B). Examining all relevant
loci on the ImmunoChip, which are more likely to come from
studies performed after the WTCCC, both local increases were
lower but more significant due to the additional data analyzed.
For consistency, we have assumed the same total h2gLD of 0.14 in
both of the data-sets when computing the local heritability
expected by chance, though this is likely an underestimate for
the dense typing on the ImmunoChip. Likewise, the densely typed
ImmunoChip sites also tag some markers outside of the variance-
component region, effectively increasing the local expectation.
Using 1,000 Genomes data, we find that a sequenced variant
within 500 kbp of the studied regions is tagged with an average r2
of 0.33 by the ImmunoChip sites in these loci, so we also consider
a local expectation where each region is increased by 1Mbp|0:33
of ‘‘flanking’’ length. However, irrespective of whether we use a
total h2gLD of 0.40 (the total h
2 estimated in previous studies
excluding MHC [42]) and/or include the flanking regions, the
local heritability identified at these loci remains strongly significant
(Table S24). Overall, the ImmunoChip data shows local h2gLD for
RA at 27 known (RA+other) autoimmune loci to be 0.032, 5:33|
higher than that explained by the individual RA GWAS SNPs
(0.006) and 3:6| higher than the joint GWAS model (0.009).
The variance-component method allows us to estimate local
h2gLD at regions that are suggestive of harboring a secondary signal
in this data. Specifically, Eyre et al. [41] analyzed these samples for
conditional association and identified six loci that had a significant
secondary signal. Predictably, when we restrict our analysis to
these loci we confirm that the joint model increases heritability by
1:8| over the associated SNP, but we also find the local h2gLD to
be even higher with a 2:8| increase over the associated SNP and
highly significant compared to local expectation (Table S25).
Though the joint analysis has high power in this large cohort, the
variance-components model still reveals additional hidden herita-
bility. Similarly, Diogo et al. [43] fine-mapped 25 known RA loci
and searched for the presence of secondary associations driven by
variants in the protein-coding sequence of biological candidate
genes, identifying strong enrichment of association at 10 coding
variants (9 loci) but no individually significant variant. We
examine these 9 loci in the ImmunoChip data and again observe
an increase in heritability from the joint analysis of 1:98|
compared to the leading SNPs, but an even higher increase in
local h2gLD of 3:11| which is more significant at P~1:2|10
{7
than the permutation-based penrichment~6:4|10
{4 reported by
Diogo et al. (Table S25).
Overall, the higher density and sample-size of the ImmunoChip
data empowers us to identify the presence of significant additional
h2gLD at known RA loci as well as known non-RA autoimmune
loci, beyond the heritability explained by standard mapping
approaches analyzing the same data.
Discussion
In this work we have sought to explain additional heritability at
known GWAS loci by using large-sample SNP data. Specifically,
we have utilized variance-components models that estimate the
total contribution of all typed markers in the sample and do not
require individual markers to be genome-wide significant. In
applying these methods we have quantified biases in the standard
h2g estimate when the underlying disease architecture is non-
infinitesimal and LD is systematically different at causal variants
(as recently identified by [30]). To address this, we have proposed
and compared several methods that seek to adjust the covariance
matrix such that this correlation between markers is accounted for.
In particular, we find the method of using LD residuals in
computing the kinship to provide accurate estimates with no
observed upward bias, in contrast to the proposed LDAK strategy
[30] which yielded upward bias in our genome-wide simulations
(though it exhibited lower mean error in imputed data). We thus
recommend that the LD-residual approach be used in preference
to LDAK when one is seeking lower bounds on the estimate of h2g,
as we are here.
Applying the LD-residual to known GWAS loci for nine
WTCCC1 and WTCCC2 traits, we see that LD-adjusted
estimates are nearly always higher than the unadjusted estimates,
suggesting that the disease architecture is indeed shifted towards
low-frequency variants for most traits. Understanding this
phenomenon and applying and LD-adjustment method is
therefore important for accurate estimation of h2g in future studies.
An alternative framework is the Bayesian sparse linear mixed
model, which attempts to infer the underlying genetic architecture
jointly with the h2g and can provide more accurate estimates under
certain disease architectures but requires significant computational
resources (e.g. running time of 77 hours for a data set with 3,925
samples) [44].
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Looking at previously known GWAS loci, we showed by
simulation that the LD-residual adjusted variance-components
approach is not inflated and can uncover additional heritability
beyond that observed by the leading tag SNP, particularly when
there are multiple underlying causal variants or tags. In analysis of
nine dichotomous traits, we find a significant average increase in
heritability explained of 1:29| (combined P~3:3|10{05), with
three traits exhibiting individually significant increases consistent
with the presence of multiple causal variants on average. The
latter finding is supported by previous work showing that loci with
a single causal variant are unlikely to explain substantially more
heritability then the GWAS SNP and hypothesizing multiple
underlying causal variants [8]. However, though our simulations
show that increased heritability is an indicator of multiple causal
variants on average, the current sample size is not sufficient to
reject the possibility that this local increase is caused by a single
causal variant being poorly tagged by the leading GWAS SNP. We
extrapolate that as sample sizes reach the tens of thousands our
method can conclusively draw distinctions between these two
scenarios.
Because the LD-unadjusted method tends to be deflated when
the underlying causal variant is low-frequency (Table 1), we can
use the unadjusted estimate as an indicator of the causal allele
frequency. The fact that all but one of these traits exhibit an
unadjusted local h2g that is higher than the h
2
GWAS strongly suggests
that the bulk of causal variation at these known loci does not lie in
low-frequency variants. This is consistent with the recent findings
of Hunt et al. [45] in a large-scale sequencing study that
demonstrated minimal rare-variant heritability for 25 known
auto-immune disease risk genes. This is in contrast to our genome-
wide analysis that yielded additional heritability after LD-
adjustment, indicative of a shift toward low-frequency markers.
Taken together, we hypothesize that the causal frequency
spectrum at these known loci is substantially different from that
of the rest of the genome. In light of this finding, we caution
against extrapolating the genome-wide disease architecture from
known GWAS loci, as done in Hunt et al. and other studies [45–
48].
We also applied this technique to loci that have been discovered
in related traits but not in the focal trait. Additional variation
would be found in instances where causal loci are shared across
multiple traits but have only been mapped in one trait, allowing us
to estimate the efficacy of a fine-mapping study design incorpo-
rating these loci. For autoimmune diseases we see a significant
amount of excess heritability at such related-trait loci with an
average of 6:78| more than expected by chance. Relative to the
known h2GWAS, the greatest increase from the union of trait-specific
and related-trait loci is observed in MS (7:15|) and CD (2:20|).
This finding is substantiated by the fact that non-autoimmune
traits exhibit no such significant increase and serve as negative
controls. Where previous studies have documented overlap
between causal variants from autoimmune disease [22,40], we
show that this is a wide-spread phenomenon expected to account
for an average of 27% of total h2gLD over five auto-immune traits.
Our analysis is complementary to recent methods that construct
multivariate variance-components models which directly estimate
the genetic correlation between multiple traits [23,24]. In contrast
to those studies, our approach requires only the genetic
information from a single trait of interest, allowing us to analyze
components of heritability between many autoimmune traits
without having their genetic data. Looking forward, this strategy
can be used to analyze other classes of related phenotypes such as
metabolic traits [24] and psychiatric disorders [36]. Given that we
observe GWAS loci to have fundamentally different disease
architectures from the rest of the genome, our method will still not
capture the genome-wide correlation between the two traits. A
potential future application is local heritability analysis with the
multivariate variance-components model, merging these two
strategies.
For RA, we repeated our analysis in a much larger cohort typed
on the ImmunoChip and found significant additional heritability.
Where the GWAS analysis of this data by Eyre et al. [41] found 6/
45 loci containing a secondary marker, we quantify the overall
amount of additional heritability to be 2:4| than h2GWAS. While
Eyre et al. identified a significant correlation between their
associated loci and genes with auto-immune function, we
additionally observe 19| more heritability than expected by
chance in non-RA auto-immune loci (Table 2), a highly significant
increase. These findings demonstrate the effectiveness of our
method in quantifying components of heritability from high-
density data. Loci from the other traits we examined have also
recently been analyzed large fine-mapping studies. Jostins et al.
[40] found that 30/163 loci associated with Crohn’s Disease or
Ulcerative Colitis exhibit significant secondary effects, and all loci
have an 8| higher chance of being associated with immune-
function genes. Likewise, we observe significant local and related-
trait heritability for Crohn’s Disease. On the other hand, Shea et
al. [25] re-sequenced one locus for T2D and Maller et al. [20]
densely genotyped 11 loci for CAD and T2D, with neither study
identifying significantly more heritability. This too is consistent
with our failure to observe significant increases in heritability for
these traits, though both sets of negative results may be due to the
small number of loci and samples examined.
Two recent publications by Ehret et al. and Ke [16,17] propose
methods to quantify the amount of recoverable heritability at
known loci by selecting a conditional linear model. The conceptual
distinction between these methods and our approach is that they
explicitly focus on a pruned and p-value restricted set of markers
and are therefore limited by power to detect association within the
analyzed sample. The Ke strategy differs from that of Ehret et al.
in the specific threshold values and that it does not depend on an
external set of samples for estimating unbiased effects; as such, it is
likely to be the less conservative estimate of local heritability and
the one we selected for comparison. Because these strategies only
focus on loci where conditionally nominal SNPs are present, they
do not provide a complete analysis of all known loci together.
While it is possible to incorporate many more SNPs into a
complex multiple regression and estimate the total fraction of
phenotypic variance explained, this estimate will be highly biased
proportional to the effective number of SNPs divided by the
effective number of samples, a difficult ratio to quantify in the
presence of LD between SNPs and sample structure. On the other
hand, the local variance-components model provides an approx-
imately unbiased estimate of the total heritability explained by all
SNPs, allowing us estimate components from putative loci without
significant associations, as we do here with related traits. Both in
simulations and in real data, we find that our strategy identifies
more additional variation than the standard linear model.
One limitation of the current variance-components strategy is
that analysis of ascertained case-control traits can lead to
underestimates of h2g when the ratio of SNPs to samples is low
(A.L.P., unpublished data), as can be the case when analyzing a
small number of loci. This would lower the power to detect
significant additional heritability and yield local estimates that are
a conservative lower bound. Quantifying and correcting for this
phenomena in case-control traits is an important area of future
study. Other future directions for this work include the estimation
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of local heritability over more complex annotations of putative
regions [49] as well as the use of local heritability for mapping
previously unknown loci akin to group-wise tests [50,51].
The torrent of large-scale sequencing studies will do much to
inform our understanding of the genetic architecture of common
diseases, but the design of such studies also motivates the inference
of disease architecture from currently available data. The
strategies outlined here demonstrate a great diversity of allelic
heterogeneity within and between traits, informing our assump-
tions for future GWAS and fine-mapping analysis.
Methods
Data
We examined data from the Wellcome Trust Case Control
Consortium (WTCCC) versions 1 and 2. These datasets have been
outlined in [13] and [12,40], and we provide summary details in
Table S1. Unlike GWAS studies, heritability estimates can be
particularly sensitive to individually small artifacts/batch-effects
[52], which can add up over many SNPs to exhibit false
heritability [29]. To account for this, we apply several additional
layers of quality control.
We also examined 23,092 samples of European origin typed on
the ImmunoChip platform (32% cases for Rhematoid Arthritis),
recently analyzed for association by Eyre et al. [41]. For this data,
we followed the QC protocol of Eyre et al. [41] and also excluded
any SNPs below 1% allele frequency.
WTCCC quality control. For all analysis of real phenotypes,
we performed rigorous quality control to account for genotyping
error. For each cohort, we removed any SNPs that were below
0.01 minor allele frequency, above 0.002 missingness, and had
deviation from Hardy-Weinberg equilibrium at a p-value below
0.01. Then, for each case-control cohort we removed SNPs that
had differential missingness with p-value below 0.05. The entire
procedure retained approximately 140,000 markers in each
WTCCC1 case-control cohort; 450,000 markers in the
WTCCC2-UC; and 400,000 in the WTCCC2-MS (Table S1).
Genetic structure due to ancestry has been shown to introduce
subtle biases into h2g estimates. This is a particularly serious
problem for local estimates, where ancestry can explain additional
variation in phenotype from other parts of the genome. To
account for this, we excluded one of any pair of samples with
normalized SNP covariance §0:05 and carried out principal
components analysis to identify the 20 most significant eigenvec-
tors within the QC genotypes. We subsequently performed five
rounds of outlier removal whereby all individuals more than 6
standard deviations away from the mean along any of the top 20
eigenvectors were removed and all eigenvectors recomputed. The
entire QC process retained approximately 4,300 samples in each
WTCCC1 case-cohort; 8,000 samples in the WTCCC2-UC
cohort; and 15,000 samples in the WTCCC2-MS.
For all autoimmune diseases analyzed (RA, CD, T1D, UC, MS)
we also exclude from the analysis any SNPs in the region around
the MHC locus (chr6:26–34 Mbp), which has been repeatedly
documented to have a complex LD structure and many
heterogeneous variants of strong effect for these traits. Heritability
of genotyped SNPs for BD, CD, and T1D (with/without the
MHC) have previously been reported [29].
Imputation. After performing quality control on the
WTCCC1 samples, we also performed imputation from the
1,000 Genomes Project [31] reference panels (Integrated Phase 1
v3). A total of 36,648,992 SNPs in all 1,092 samples from all
reference populations were analyzed together. All WTCCC1
samples were analyzed together, with each chromosome first
pre-phased using the HAPI-UR algorithm [53] (see Web
Resources) with standard parameters and three rounds of phase
inference followed consensus voting. Next, we ran IMPUTE2 [54]
on the pre-phased data in windows of approximately 1 Mbp and
default parameters. The full panels were used as a reference and
only those imputed markers with an IMPUTE2 information
metric higher than 0.6 were retained, for a total of 8.2 million
imputed and genotyped SNPs. Finally, the same QC thresholds as
those used for genotypes were applied on the imputed data except
the maximum locus missingness threshold was increased to 0.05 as
we expect batch effects to have less impact in this post-QC data.
The final set of genotypes contained approximately 2.17 million
imputed and genotyped SNPs per cohort. Due to the larger sample
size and SNP density of the WTCCC2 data, we did not perform
imputation for the UC and MS cohorts.
Estimating heritability of typed SNPs
Variance components estimation. The variance-compo-
nents method has previously been described in [33], and we
summarize it here. Formally, we assume the phenotype is
generated from a model y~
P
i biWize where bi and Wi are
the effect-size and genotype coding of SNP i, and e is
environmental noise. Given a kinship matrix that relates all pairs
of individuals, the phenotype variance is then defined as
V (y)~Ks2gzs
2
e where, assuming all of the SNPs have been
rescaled/normalized to have equal mean and variance,
s2g~
P
i b
2
i and the narrow-sense heritability h
2
g~s
2
g=(s
2
gzs
2
e).
While the kinship matrix K ideally represents the exact sample
covariance over all causal variants, these values can be partially
estimated directly from high-density SNP panels by computing the
genotypic relatedness matrix (GRM) as K~WW ’=M over the M
normalized SNPs in W . The variance-components can then be
inferred using likelihood maximization under the assumption that
SNP effects arise from the multivariate Normal distribution.
Variance explained by the GRM is estimated jointly with a
residual component (the identity matrix) using restricted maxi-
mum likelihood (REML) [55], which properly accounts for the
fixed-effects in the likelihood function. The Average Information
coefficients [56] together with the first derivatives of the log
likelihood function with respect to each variance component are
used to iteratively converge on the corresponding heritability
estimates. The inverse of the final Average Information matrix
yields an estimate of the corresponding covariance matrix of the
variance-component estimates [57] which is used to convert the
variance-component estimates into h2g (by the Delta Method) as
well as obtain the corresponding standard error of the h2g and h
2
e
values (referred to here as the ‘‘analytical’’ standard error). In
practice, a single affine-term (vectors of 1 s) and the top 20
principal components were also included as fixed-effects to
account for population structure in all local and global estimates
of heritability from real phenotypes (h2GWAS, h
2
g, h
2
gLD, and
h2gLDAK). The estimation was performed using the GCTA software
[58] (see Web Resources).
Liability-scale transformation for ascertained traits. Our
analysis focuses on case-control traits with non-random ascertain-
ment which makes it difficult to compare observed-scale heritability
estimates across diseases or with other studies. To mitigate this, we
assume the classical liability-threshold model [59] and also report all
of our findings transformed to the liability scale. This transformation
uses the proportion of cases in the sample P and the proportion of
cases in the population, or prevalence k to transform an observed h2
value to liability-scale:
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h2of liability~h2
(k(1{k))2
Z2(P(1{P))
where Z is the height of the standard normal probability density
function at the threshold that truncates the proportion k [32,59].
The standard error of the estimate can be transformed accordingly.
Because this transformation to heritability of liability is linear, any
ratios and p-values we report for the transformed estimates are
unaffected. We note that the accuracy of the transformed value
depends on the level of trait ascertainment as well as the degree of
relatedness in the cohort. [29] demonstrated the the transformation
is robust in the WTCCC1 traits and we have also explicitly pruned
the samples for related individuals, so we do not expect errors in the
transformation to effect our results but care should be taken in
applying this method to highly-ascertained or related cohorts.
Accounting for non-uniform LD
The variance-components model assumes an idealized infini-
tesimal genetic architecture where every marker is causal and
effect-sizes are normally distributed over the normalized variants.
[33] showed that the model remains unbiased when causal
variants are randomly sampled from the typed SNPs (though the
analytical standard error on the estimate does exhibit bias as the
number of causal variants becomes very low [30]). However, as
demonstrated in [33], when causal variants are not randomly
drawn from the typed SNPs, LD between markers can lead to
over-representation of certain SNPs in the sample GRM and
distort the estimated relationships between individuals, thereby
distorting the final estimate of SNP-heritability. We describe and
evaluate several methods that account for correlations between
markers when constructing a GRM. In all cases, the goal is to
reweigh or transform each SNP so that it is equally represented in
a new adjusted genotype matrix. We caution that our simulations
do not explore the robustness of this model in the presence of very
rare variants (e.g. whole-genome sequence) where assumptions of
normality may be strongly violated.
LD-pruning. One of each pair of markers that surpasses a r2
threshold is removed from the analysis. Formally, a sliding window
is moved across the genotype matrix and the marker with the
highest number of pairs over the threshold is removed greedily
until no such markers exist. The GRM is then computed in the
standard way over the remaining SNPs. Other estimates of
heritability have been previously performed with r2 thresholds in
the range of 0.1–0.3 [16,42] and so we use 0.3 in our analysis.
Lower thresholds are more likely to address the LD-bias, but will
also lose more heritability due to SNPs with non-redundant
information being excluded.
Transformation by linear regression (LD-
residual). Following the strategy proposed in [60], a new
genotype matrix Wr is generated where each marker is regressed
onto the l markers preceding it and transformed into the residual:
Wri~Wi{W½i{l,i{1(W
0
½i{l,i{1W½i{l,i{1)
{1W
0
½i{l,i{1Wi
Each new genotype is then independent of the linear combination
of preceding markers. If we consider the simple case of two
markers that are highly correlated, this procedure will shrink the
second marker to be the residual of the first with variance equal to
one minus their squared correlation, effectively removing the
redundant contribution from the analysis.
It’s important to note that Wr does not maintain the standard
properties where each marker has s2~1, therefore the resulting
GRM Kr must be normalized by sum of the empirical variance:
Kr~WrWr
0
=
X
i[½1,m
var(Wcr )
We use a SNP window that corresponds to the preceding 100 kbp
(500 kbp for imputed data) and (arbitrarily) remove one of any
pair of SNPs that have an r2w0:95 so that the relevant matrix
inversions can be performed. We refer to estimates of heritability
from the LD-residual matrix as h2gLD.
Reweighting by pairwise correlation (LD-
shrink). Following the method described by [61] for population
structure, we re-weight each marker according to the number of
neighboring markers in high r2. Formally, a weight is computed
across the l nearest markers:
wi~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃX
j[½i{w,izw
r2ijI½r2ijwc
s
where r2ij is the Pearson squared-correlation between genotypes i
and j; and I½r2ijwc is a zero/one indicator for when the
correlation surpasses threshold c. The markers are then re-
weighted to form a new genotype matrix Wc, where the columns
Wci~Wi=wi. A final GRM is then computed and normalized by
the sum of individual weights:
Kc~WcWc
0
=
X
i[½1,m
1=wi
We set an l of 150 SNPs and c cut-off of 0.2 as suggested by [61].
LDAK. Recently, the impact of LD on heritability estimates
was also quantified by Speed and colleagues [30], who propose a
method for reweighing markers to account for LD. Their method,
LDAK, examines the local SNP correlation matrix and computes
optimal SNP weights by solving a linear program. This re-
weighing can be thought of as an optimal variant of the Zou et. al.
approach that also accounts for SNP distance. Both of these
strategies are fundamentally different from our regression
approach in that they only adjust the SNP weights rather than
the SNPs themselves. We apply the LDAK 1.4 algorithm with
default parameters (500 predictors for array, 1000 predictors for
imputation). We refer to estimates of heritability from the LD-
residual matrix as h2gLDAK.
Averaging over 10 runs, chromosome 1 of the WTCCC data
(roughly 10% of the genome) was processed by LDAK in
1271 seconds, requiring 1426MB of memory; the LD-residual
analysis implemented in EIGENSOFT (see Web Resources) took
1181 seconds, requiring 676MB of memory.
Analysis of known GWAS loci
Standard GWAS analysis. For each trait, we identified
known associated SNPs from the NCBI published GWAS catalog
(version 2013-03-06). Any marker that is present in our typed or
imputed data (after QC) defines a locus in the linear model and
variance-component. We then include all known GWAS loci
together in a linear model and compute the R2 or variance-
explained by the model. As in [16], we shrink the estimate by
subtracting 1=N for each of the SNPs included (where N is the
number of samples) and then transform to the liability scale. For
the loci where multiple variants are present within a single
megabase, we only include the single most associated SNP in this
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data (all SNPs are considered in the joint/conditional analysis
described below). All SNP counts and allele frequency distributions
for GWAS loci are detailed in Table S26.
Joint/conditional analysis. We follow the procedure out-
lined by Ke [17] for step-wise construction of a linear model which
attempts to explain conditionally independent sources of associ-
ation. Specifically, we include all known GWAS markers as initial
predictors and all other nearby SNPs in the initial pool of m total
putative predictors. We perform a standard univariate association
and remove any markers that do not surpass a p-value of 0.05
corrected for m tests. We then iteratively add the conditionally
most associated SNP to the model until no marker is conditionally
significant at P~0:05. For loci where no marker is significant, we
therefore only include the known GWAS markers (though a strict
adherence to the Ke procedure would entirely exclude such loci
and decrease the overall estimate). The final measure of
h2GWAS,joint is then the R
2 or variance-explained of the final
model; shrunk by subtracting 1=N for each of the predictors in the
final model (where N is the total number of samples); and
transformed to the liability scale. This procedure is similar to the
model selection in [15] but we require SNPs to be conditionally
significant at P~0:05 rather than at P~5|10{8, making this
estimate much less conservative than the one in [15] (ignoring
differences due to meta-analysis).
Estimating components of local heritability. For all
GWAS loci used in the standard analysis, we include the
associated SNP(s) and a window of all surrounding SNPs into
the computation of a single local genetic relatedness matrix
(different window sizes were tested, see below). Separately, LD
adjustment is performed on each locus individually and then
combined into a single GRM to estimate the LD-adjusted
heritability (h2gLD, h
2
gLDAK). This yields three different models for
which the corresponding heritability is then estimated as described
above. An alternative strategy of including the GWAS markers as
fixed-effects was considered but resulted in under-estimation of the
h2GWAS when the fixed and random-effects are highly correlated
due to extensive LD between the GWAS variant and surrounding
SNPs, and thus was not used.
We also compute local h2g (and corresponding LD-adjusted
values) in known GWAS loci from related traits. The procedure is
identical to the GWAS analysis but includes only those loci not
associated in the focal trait but associated in any related traits. For
this autoimmune class, we pool all loci from Celiac disease,
Crohn’s disease, Graves’ disease, Multiple sclerosis, Psoriasis,
Rheumatoid arthritis, Systemic lupus erythematosus, Type 1
diabetes, and Ulcerative colitis that are reported in the NCBI
catalog. In all cases, total h2g, h
2
gLD, or h
2
gLDAK is used where
appropriate.
Statistical significance of increase in local h2g. For
hypothesis testing, we compute the local expectation as
h2null~h
2
GWASzl  (totalh2g{h2GWAS) where l is the physical
fraction of the genome corresponding to these loci. We report
the relative increase of (localh2g)=(h
2
null) and compute the statistical
significance of this increase by Z-test using the analytical standard
error (see above). The same procedure is performed for the LD-
adjusted estimates h2gLD and h
2
gLDAK with corresponding genome-
wide h2g estimates. This approximation based on physical fraction
can be biased if the SNP density or LD properties of GWAS loci
are substantially different from the rest of the genome. To
investigate this bias, we computed local expectation using two
alternative measures of l: % of SNPs; and % of SNP variance after
transforming to the LD-residual. The latter metric is computed as
the sum of individual SNP variances after LD-residual regression
divided by the corresponding genome-wide sum. This results in
regions of high-LD having a reduced contribution compared to
physical or SNP size to account for the presence of redundant
SNPs. We find these measures to be highly correlated across the
nine traits (rw0:99 between either metric and l based on physical
length), though the % of LD-residual SNP variance is generally
higher. However, though the absolute increase in cross-trait
analysis did vary across the different metrics (because h2GWAS~0
and h2null is therefore directly related to l) the measures of statistical
significance remained consistent and all previously significant
estimates remained significant (Table S27).
We do not model the noise on h2GWAS because both h
2
gLD and
h2GWAS are estimated from the same set of SNPs resulting in these
models being partially nested and not independent. We demon-
strate this by generating 200 random simulations with a single
typed causal variant and regressing h2GWAS on h
2
gLD with an
intercept, yielding a highly significant effect at P~3:4|10{06 and
an R2~0:10. Likewise, we do not model the error around h2null
because we are quantifying the observed enrichment of h2gLD
within the same samples that were used to estimate h2null. The high
concordance of our analytical p-values and those established
empirically by sampling random regions (see below) confirm that
this assumption is valid.
To ensure that our choice of window size did not significantly
impact the results, we performed both the within-trait and related-
trait analysis in the WTCCC data while varying window-sizes
from 100 Kbp - 2 Mbp (Figure S6,S7). For the within-trait GWAS
analysis, the increase in heritability is primarily dependent on the
h2GWAS and is therefore stable across all windows. On the other
hand, for related-trait analysis the increase in heritability is
primarily dependent on the window size, and we observe this
strong relationship in the real data. However, we found the
significance of increase (computed by z-test) to be stable across the
windows tested, and therefore present results from 1 Mbp
windows in our main analysis (Figure S6,S7). The LD-residual
adjustment is performed in a left-to-right sliding window and could
therefore be subtly impacted by SNP ordering. We also re-ran
both the trait-specific and related-trait analysis with 1 Mbp
window parameters but SNP order reversed, yielding results that
were nearly identical (average absolute difference of 0:23s) which
we do not expect to impact our results.
Empirical estimates of significance. Computing signifi-
cance based on the analytical standard error of each measure of h2g
assumes that the analytical standard error is both well-calibrated
and normally distributed, and that the genome-wide h2g is uniform
throughout the genome. We relax these assumptions by using an
empirical expectation from randomly sampled regions and
comparing the randomly observed enrichment to our observed
enrichment at GWAS loci. Specifically, for each trait we randomly
draw a number of 1 Mbp regions equal to the number of GWAS
loci tested in that trait and compute h2g,local,i and h
2
gLD,local,i at the
union of these loci, performing 1,000 such draws per trait with
replacement (or 10,000 for highly significant traits, marked with
asterisk). We then compare the (h2g,local{h
2
null) observed at GWAS
loci (Table S18) to the sampled (h2g,local,i{h
2
null) (conservatively
assuming that the sampled h2GWAS,i~0) and compute an empirical
p-value equal to the number of sampled differences that exceed the
observed difference (and likewise for h2gLD,local). This comparison
quantifies how likely the increase we observe in local heritability at
GWAS loci is expected to occur by chance at random loci in the
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genome. Like traditional permutation testing, this procedure does
not make assumption of normality, but also captures the true
underlying disease architecture of each trait. For the cross-trait
analysis, we follow the same procedure but require the random
draws to not overlap with known GWAS loci for that trait, as in
the real cross-trait analysis.
We find that the resulting empirical p-values are highly
consistent with our analytical approximations (Table S17, Figure
S5), with the latter appearing over-conservative for the standard h2g
case. All instances that were previously significant (within-trait:
CD, UC, and MS; related-trait: UC, CD, RA, T1D) remain
significant in the empirical analysis, with T1D also reaching
Pv0:05 in the within-trait analysis. MS, which was highly
significant by z-test in both instances, did not result in any random
samples that were more enriched (Pv1=1000). Overall, the strong
consistency between these assumption-free estimates lend validity
to our analytical approximations of significance. Based on this
concordance and the technical restriction on empirical p-values to
a minimum of Pv1=1,000 or Pv1=10,000, we report the
analytical p-values in our main results.
Correcting for genic enrichment at GWAS loci. In the
related trait analysis, our primary negative control is the lack of
significant enrichment among the unrelated traits. However, one
potential concern is that a latent correlation between known
GWAS loci and gene-coding regions could falsely inflate the
relative increase if gene-coding regions systematically contribute
more to phenotype. Indeed, recent work partitioning heritability
has shown that SNPs near exons contribute significantly more to
genome wide h2g than others [62]. Following the analysis of [62],
we define ‘‘genic’’ as any marker within 10 kbp of known exons.
Averaged across all data sets, genic SNPs account for 50% of all
SNPs and 60% of SNPs in known autoimmune loci, a strong
enrichment (Table S21). We computed the fraction of genome-
wide h2gLD from these genic regions using a joint variance-
component model where SNPs from the two region types are
modeled in two corresponding components and heritability is
estimated jointly. On average, we found that 64% of the total joint
estimate comes from the coding component (Table S21). To
account for this enrichment, we modify our computation from
h2null~l  (total h2gLD) to a weighted average of the two region
types:
h2null~lgenic(total h
2
gLD,genic)=pg
z(lnon{genic(total h
2
gLD,non{genic)=(1{pg)
where lgenic is the fraction of genome covered and genic; lnon{genic
is the fraction of genome covered and non-genic; total h2gLD,genic is
the variance explained by jointly modeled genic regions;
total h2gLD,non{genic is the variance explained by jointly modeled
non-genic regions; and pg is the fraction of the whole-genome thats
genic. Using this new local expectation, we re-calculated the
relative increase of local h2gLD (Table S21). Although the relative
increase is slightly lower after this adjustment, all of the traits that
were previously significant remain significant and the overall trend
persists.
PCA-based matching. Multiple Sclerosis has previously
been shown to have a high degree of population structure
correlated with the trait, which could uniquely bias the MS
heritability analysis. To guard against this, we also compute all of
our local heritability statistics in cases and controls that have been
matched by their top principal components. The matching is
performed by reweighing each of the 20 eigenvectors based on each
of their R2 to the phenotype and then computing a Euclidean
distance between cases and controls based on the reweighed
eigenvectors. For each control, we greedily select the nearest case
sample in this space and retain the pair of samples for analysis,
iterating until no pair of samples is available. This procedure
corresponds to a (greedy) pair match, demonstrated by [63] to
effectively control for population structure. After matching and
excluding outliers, a total of 8,149 samples were retained with no
apparent differences in underlying structure among the main
principal components (Figure S8). Local heritability analysis on these
matched samples did not yield substantially different results from the
full dataset (Table S28), though it did substantially increase the
h2GWAS. For consistency, we included the original 20 principal
components as fixed-effects in the analysis to account for any
lingering population structure that was not captured by the matching.
Simulated quantitative trait loci
Genome-wide. For simulations involving genome-wide esti-
mates of heritability and the impact of LD, we used the
WTCCC1:CAD cohort to simulate phenotypes and infer compo-
nents of heritability with the previously described methods. We
sampled 5,000 of the genotyped SNPs to be causal variants such
that a fraction f of the markers is low-frequency
(0:01vMAFv0:05), varying f between 0 and 1 in increments
of 0.1. We applied allelic effect-sizes drawn from a distribution
with mean zero and variance 1/p(1{p) where p is the variant
allele frequency. We generated quantitative phenotypes using the
polygenic model with normally-distributed residual variance
added to achieve an h2 of 0.80. In all simulations the causal
variants were always present in the GRM.
Local. We estimated the expected effectiveness of the
variance-components strategy to identify additional local herita-
bility beyond the GWAS SNP by simulating phenotypes over real
genotypes from the analyzed platforms. We emulate the disease
architecture identified by Lango-Allen et. al [4], where 180 loci
explained approximately 10% of the variance in height. Over
multiple trials, we randomly sample 180 1 Mbp loci from the SNP
data centered on 1, 2, 3, 5 or 10 casual variants in each locus. The
variants are all selected either from minor allele frequency below
5% (low-frequency) or above 10% (common) to create possible
disease architectures. For each disease class and locus set
combination, we generated quantitative phenotypes using the
polygenic model with normalized SNP effect sizes drawn from the
standard normal and normally-distributed residual variance added
to achieve an h2 of 0.1 (such that each SNP explains equal
phenotypic variance in expectation). The causal variants were then
hidden from subsequent analysis and local h2g (or LD-adjusted
h2gLD and h
2
gLDAK) estimated.
For each locus, we specify the ‘‘GWAS SNP’’ to be the single
best tag of the true causal variants. In instances where multiple
causal variants are present at a locus, this tag is the one SNP with
highest unbiased effect-size. Formally, given that each locus l
contains set Cl of (at most 10) causal variants and ml typed GWAS
SNPs, we compute the effect of the GWAS SNP as:
b2GWAS,l~max
i[ml
(max
j[Cl
r2ijb
2
j )
This value represents an idealized scenario where the GWAS SNP
explains the most phenotypic variance at the locus with no
sampling noise. The heritability h2GWAS is then calculated as a sum
over all b2GWAS,l .
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For the local h2g, h
2
gLD, and h
2
gLDAK we construct adjusted and
unadjusted GRMs over the entire set of typed SNPs and estimated
their total contribution to heritability using the standard REML
approach described previously. All analyses were performed over
50 independent trials in WTCCC1-CAD (Table S5) and
WTCCC2-UC (Table 2) data with randomized causal SNP effect
sizes.
Local in ImmunoChip. This procedure was modified for
simulations in ImmunoChip, requiring the ‘‘GWAS SNP’’ to be
selected only from variants in the WTCCC1-RA post-QC data.
This reflects the same constraint applied in the real-data analysis,
which focused only on associated loci that overlap between the
WTCCC RA samples and the ImmunoChip. The result is a
marked decrease of h2GWAS compared to either of the WTCCC
simulations, particularly at low-frequency variants (Table S23).
Intuitively, this is due to the fact that a causal SNP drawn from the
WTCCC array is more likely to be tagged by another WTCCC
SNP than a causal SNP drawn from all existing SNPs. The
comprehensive assay of variants on the ImmunoChip thus yields
simulated causal SNPs that are not as well tagged by WTCCC
SNPs as simulations on the WTCCC data itself. For a disease
model where causal variants are randomly drawn from all low-
frequency SNPs, the ImmunoChip simulations are therefore more
representative of real-life GWAS tagging effectiveness. Likewise,
we observe an h2GWAS,joint computed over all SNPs that is
approximately equal to that observed in WTCCC data for a
single causal variant but higher on average over multiple causal
variants due to a greater pool of potential SNP tags.
Diverse simulations with imputed variants. To investi-
gate more thoroughly the impact of causal allele frequency on
components of local heritability we performed a set of simulations
using the 1,000 Genomes imputed SNPs in a realistic small-scale
analysis of 28 loci with total h2g~0:02 (corresponding to the mean
we observed in the WTCCC data). As before, we simulated disease
architectures with 1, 2, 3, 5, and 10 causal variants per locus but
allowed the causal SNPs to be sampled from the genotyped and
1,000 Genomes imputed markers. We then inferred the local
components using either genotyped SNPs only or genotyped and
imputed SNPs together. Finally, we performed these simulations in
two large runs with the underlying allelic effect-sizes drawn from
either the standard normal or a distribution with mean zero and
variance 1/p(1{p) where p is the variant allele frequency (such
that each causal SNP explains equal phenotypic variance in
expectation, as in the main Results section). These two architec-
tures are expected under a model of no selection and very strong
selection, respectively, providing us with estimates from the two
most extreme scenarios. In each simulation, we compared the
performance of the following five methods at maximally recover-
ing the local heritability (when causals are hidden) or quantifying it
without bias (when causals are observed): h2GWAS, h
2
GWAS,joint, h
2
g,
h2gLD, h
2
gLDAK.
Tables S8,S29 detail the results for observed causals with the
frequency-normalized architecture, again demonstrating the sig-
nificant deflation of the standard h2g estimates when causal variants
are rare (inferring only 0.67 of the true local heritability on
average) and inflation when causal variants are common (inferring
1.10 of the true local heritability on average). The two LD
adjustment strategies both account for these biases, exhibiting no
upwards inflation and no statistically significant differences
between the two. For the LD adjusted methods, including imputed
SNPs in the analysis increases the observed heritability but not the
gain relative to h2GWAS yielding an overall decrease in power to
detect additional heritability. These trends were also consistent in
simulations of normally distributed effect sizes (Tables S9,S30)
with only h2g performing better due to the lessened impact of low-
frequency variants. When variants were hidden (Tables
S6,S10,S7,S11) we again see that two LD adjustment schemes to
have no statistically significant differences and lose power when
incorporating imputed variants. Both disease architectures yield
comparable results.
Like the genome-wide simulations, we conclude that LD
adjustment is a necessary step to getting well-controlled estimates,
though we no longer observe a significant difference between the
two adjustment methods (LD residual and LDAK). Across all
simulations, we see that these methods can detect significantly
more heritability when multiple causal variants exist at the locus
and yield only slightly higher estimates when there is a single
causal SNP.
Web resources
Open-source software implementing the LD residual adjust-
ment we have described is implemented in EIGENSOFT 5.0 at
http://www.hsph.harvard.edu/alkes-price/software. HAPI-UR soft-
ware is available at https://code.google.com/p/hapi-ur/ GCTA
software is available at http://www.complextraitgenomics.com/
software/gcta/
Supporting Information
Figure S1 Impact of allele frequency on h2g estimate (h
2~0:80).
Five strategies for computing h2g are compared under a disease
architecture with 10,000 causal variants increasingly selected from
low-frequency SNPs (x-axis). Top panel shows results from
phenotypes simulated on 270,000 real WTCCC1-CAD SNPs,
bottom panel shows results from phenotypes simulated on
3,900,000 typed and 1,000 Genomes imputed SNPs. Default
(IBS) estimate can be slightly inflated or highly deflated depending
on disease architecture. Error bars represent observed standard
error from 50 random trials.
(PDF)
Figure S2 Impact of allele frequency on variance of h2g estimate.
Four strategies for computing h2g are compared under a disease
architecture with 10,000 causal variants increasingly selected from
low-frequency SNPs (x-axis). Colored bars represent the mean
analytically expected standard error of the SNP-heritability
(see Methods) over 50 simulations. White bars represent the
observed standard deviation of the estimate over the same
simulations.
(PDF)
Figure S3 h2g estimate with no LD (h
2~0:80). Inference of h2g
from SNP’s randomly permuted to remove LD but maintain allele
frequency spectrum. No bias is observed under any tested causal
variant frequency distribution.
(PDF)
Figure S4 Heritability of liability genome-wide SNPs for seven
complex traits. Components of heritability for typed markers (blue)
over nine traits and imputed markers (green) over seven
WTCCC1 traits shown. Light bars correspond to estimates from
the standard variance-component and dark bars correspond to
estimate from LD-adjusted variance-component. Two control sub-
groups (NBS and 58C) tested against each other as negative
control; diseases tested are Bipolar Disorder (BD), Coronary
Artery Disease (CAD), Crohn’s Disease (CD), Hypertension (HT),
Rheumatoid Arthritis (RA), Type 1 Diabetes (T1D), Type 2
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Diabetes (T2D), Multiple Sclerosis (MS), Ulcerative Colitis (UC).
All traits exhibit an increase after LD adjustment, indicative of a
genetic architecture that is shifted towards low-frequency causal
variants. Hypertension, which has a family-based estimate of
liability-scale heritability close to 1.0, has been hypothesized to be
poor fit to the liability-scale transformation [64], and is presented
here for completeness.
(PDF)
Figure S5 PP-plot for empirical analysis of heritability enrich-
ment. Analytical p-values from estimated h2g standard error are
plotted against empirical p-values estimated from 1,000 randomly
sampled regions (10,000 random samplings for phenotypes with
asterisk). Top and bottom panels show within and cross-trait
analysis; right and left panels show results with and without LD-
adjustment. Each p-value position is labeled with the correspond-
ing trait. Dashed red lines indicate significance at Pv0:05 and
solid red lines indicate significance after accounting for nine traits.
Analysis where no random sample was observed as more enriched
are shown at y~0. MS was highly significant, with no stronger
than random samples observed under any of the four tests, and it is
excluded from the plot.
(PDF)
Figure S6 Increase and Z-score of increase in local heritability
measures at known GWAS loci. Components of heritability were
inferred around known GWAS loci with a range of locus sizes
(100 Kbp - 2 Mbp) and increase compared to h2GWAS and local
expectation is shown. Absolute increase, dependent primarily by
h2GWAS is mostly unaffected by locus size. MS and UC exhibit
significant increases at all locus sizes, CD at $500 Kbp.
(PDF)
Figure S7 Increase and Z-score of increase in local heritability
measures at known autoimmune loci. Components of heritability
were inferred around known autoimmune disease loci with a range
of locus sizes (100 Kbp - 2 Mbp) and increase compared to local
expectation is shown. Absolute increase is highly dependent on locus
size, however, statistical significance remains largely consistent
across all lengths. Autoimmune traits (CD, MS, RA, T1D, and UC)
all show statistically significant increases across most locus sizes;
non-autoimmune traits (CAD, HT, T2D) show no statistically
significant increases under any locus sizes. HLA was excluded from
all analyses of autoimmune traits.
(PDF)
Figure S8 PCA of MS samples before and after sample
matching. Principal components in MS cohort with highest
correlation to phenotype are shown before and after matching
samples based on PC coordinates.
(PDF)
Table S1 Datasets analyzed.
(PDF)
Table S2 Impact of causal variant allele frequency on fraction of
total heritability inferred by five strategies. Each row reports
results of five heritability inference strategies from disease
architectures where the fraction of causal variants sampled low-
frequency (0:01vMAFv0:05) as specified by the left-most
column. Other columns report the fraction of total heritability
inferred (averaged over 50 trials with standard error in
parenthesis), and p-value for difference from 100% by z-test.
Bold-face highlights values that are significantly different from
100% by z-test after accounting for 11 tested frequency bins. LD-
shrink, LD-residual, and LDAK attempt to account for similar
phenomena and their performance is expected to be correlated.
Raw estimates are also represented graphically in Figure S1.
(PDF)
Table S3 Bias in h2g estimates. Summary of the observed bias
in simulation for three estimates of h2g. Top row shows results
where causal variants are randomly sampled from the genotyped
SNPs and bottom row shows corresponding results for
non-random sampling of causal variants (from low frequency or
high-frequency SNPs). Where significant bias is observed,
the range of bias as a fraction of the true h2g is shown in
parenthesis.
(PDF)
Table S4 RMSE from h2~0:8 for five LD adjustment schemes.
(PDF)
Table S5 Fraction of local heritability explained in WTCCC1
simulated phenotypes. Analysis of simulated disease architecture
with 180 causal 1 Mbp loci yielding a true h2~0:1. In each locus,
1–10 causal variants were sampled from either low-frequency
(0:01vMAFv0:05) of common (MAFw0:10) WTCCC1 SNPs.
For each of four methods tested, the fraction of local heritability
identified by the method is reported over 50 simulations (with
standard error in parenthesis). Top two panels correspond to
experiments with observed causal variants and bottom two panels
to experiments with causal variants hidden. In A and B only
(causals are typed), bold-faced h2g and h
2
gLD represents significant
difference from 100% by z-score at Pv0:05=5 (accounting for 5
architectures tested). The ratio of h2gLD to h
2
GWAS is reported in the
bottom row of each panel (with bold-face indicating significance
by t-test at Pv0:05=5).
(PDF)
Table S6 Fraction of local heritability recovered in simulation
(frequency-normalized allelic effect sizes, genotyped SNPs tested).
Using 1,000 Genomes imputed variants in the WTCC1:CAD
cohort, 28 1 Mbp loci were randomly sampled with every locus
centered over a fixed set of causal SNPs (between 1 and 10).
Causal variants were sampled from low-frequency
(0:01vMAFv0:05, top panel) or common (MAFw0:10, bottom
panel) and corresponding allelic effect-sizes were drawn from a
normal distribution with mean zero and variance 1=p(1{p) such
that each causal SNP explains equal phenotypic variance in
expectation. Causal variants were combined as an additive
polygenic trait with normally distributed environmental noise set
to yield total heritability of 0.02 (number of loci and total
heritability chosen as the average over all tested traits in real data).
Reported h2 values correspond to the fraction of total heritability
recovered by each corresponding method after all causal and
imputed variants were hidden, averaged over 100 trails with
standard error in parenthesis. h2GWAS computed from single best
tag in the region (see Methods for other models). Gain columns
report the ratio of corresponding h2 to h2GWAS, with bold-face
indicating significant differences by t-test (Pv0:05). P(h2gLD vs.
h2gLDAK) column reports P-value for difference between h
2
gLD and
h2gLDAK results by Welch’s t-test.
(PDF)
Table S7 Fraction of local heritability recovered in simulation
(normal allelic effects, genotyped SNPs tested). Trait simulated and
tested as in Table S8 but allelic effect-sizes drawn from a standard
normal, such that each causal SNP explains phenotypic variance
in proportion to it’s allele frequency. Reported h2 values
correspond to the fraction of total heritability (0.02) recovered
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by each corresponding method, averaged over 50 trails with
standard error in parenthesis. Gain columns report the ratio of
corresponding h2 to h2GWAS, with bold-face indicating significant
differences by t-test (Pv0:05). P(h2gLD vs. h2gLDAK) column reports
P-value for difference between h2gLD and h
2
gLDAK results by
Welch’s t-test.
(PDF)
Table S8 Fraction of local heritability observed in simulation
(frequency-normalized allelic effect sizes, genotyped SNPs tested).
Trait simulated and tested as in Table S6 without hiding causal
variants. Reported h2 values correspond to the fraction of total
heritability (0.02) observed by each corresponding method,
averaged over 50 trails with standard error in parenthesis. Gain
columns report the ratio of corresponding h2 to h2GWAS, with bold-
face indicating significant differences by t-test (Pv0:05). P(h2gLD
vs. h2gLDAK) column reports P-value for difference between h
2
gLD
and h2gLDAK results by Welch’s t-test.
(PDF)
Table S9 Fraction of local heritability observed in simulation
(normal allelic effect sizes, genotyped SNPs tested). Trait simulated
and tested as in Table S9 without hiding causal variants. Reported
h2 values correspond to the fraction of total heritability (0.02)
observed by each corresponding method, averaged over 50 trails
with standard error in parenthesis. Gain columns report the ratio
of corresponding h2 to h2GWAS, with bold-face indicating significant
differences by t-test (Pv0:05). P(h2gLD vs. h2gLDAK) column reports
P-value for difference between h2gLD and h
2
gLDAK results by
Welch’s t-test.
(PDF)
Table S10 Fraction of local heritability recovered in simulation
(frequency-normalized allelic effect sizes, imputed SNPs tested).
Trait simulated as in Table S6 but heritability recovered from
imputed and genotyped SNPs (after hiding causal variants).
Reported h2 values correspond to the fraction of total heritability
(0.02) recovered by each corresponding method, averaged over
100 trails with standard error in parenthesis. Gain columns report
the ratio of corresponding h2 to h2GWAS, with bold-face indicating
significant differences by t-test (Pv0:05). P(h2gLD vs. h2gLDAK)
column reports P-value for difference between h2gLD and h
2
gLDAK
results by Welch’s t-test.
(PDF)
Table S11 Fraction of local heritability recovered in simulation
(normal allelic effects, imputed SNPs tested). Trait simulated and
tested as in Table S6 but heritability recovered from imputed and
genotyped SNPs (after hiding causal variants) and allelic effect-
sizes drawn from a standard normal. Reported h2 values
correspond to the fraction of total heritability (0.02) recovered
by each corresponding method, averaged over 50 trails with
standard error in parenthesis. Gain columns report the ratio of
corresponding h2 to h2GWAS, with bold-face indicating significant
differences by t-test (Pv0:05). P(h2gLD vs. h2gLDAK) column reports
P-value for difference between h2gLD and h
2
gLDAK results by
Welch’s t-test.
(PDF)
Table S12 Power to detect additional variation in 4,500
samples. Fraction of experiments where specified variance-
component estimate (h2g or h
2
gLD) was significantly higher than
h2GWAS at Pv0:05 by z-test using analytical standard error on
heritability.
(PDF)
Table S13 Power to detect additional variation in 15,000
samples. Fraction of experiments where specified variance-
component estimate (h2g or h
2
gLD) was significantly higher than
h2GWAS at Pv0:05 by z-test using analytical standard error on
heritability.
(PDF)
Table S14 Genomewide h2g and h
2
gLD of liability for all case-
control traits.
(PDF)
Table S15 Genomewide observed-scale h2g and h
2
gLD for all case-
control traits.
(PDF)
Table S16 Local heritability around known GWAS loci. Local
heritability inferred by LD-adjusted variants components is
reported for 1 MBp loci around known GWAS hits for each trait.
h2GWAS column contains the heritability coming from the top
associated SNP at the locus. h2GWAS,joint column contains the
heritability from all known associated SNPs at the locus and any
conditionally significant SNPs (see Methods).
(PDF)
Table S17 Analytical and empirical p-values for heritability
enrichment. For each locus type and trait, analytical p-values
(computed from the Average Information matrix) are compared to
empirical p-values (computed from randomly sampled genomic
regions). Random sampling was performed over 1,000 trials
(10,000 trails for phenotypes marked with asterisk).
(PDF)
Table S18 Effect of LD adjustment on heritability around
known GWAS loci. Results from three methods for estimating
local variance-components are reported, h2g (standard), h
2
gLD (LD-
residual adjusted), and h2gLDAK (LDAK adjusted). Gain column
reports corresponding h2g=h
2
null, where h
2
null is computed based on
the genome-wide h2g and locus size. P-value computed for each
h2g versus corresponding h
2
null by z-test using analytical standard
error.
(PDF)
Table S19 Heritability of known autoimmune disease loci. Local
heritability inferred by LD-adjusted variance-components is
reported for known loci associated with autoimmune disease (but
not associated for the focal trait). h2null computed from genome-
wide h2gLD and % of genome. P-value computed for h
2
gLD versus
h2null using analytical standard error.
(PDF)
Table S20 Effect of LD adjustment on heritability of autoim-
mune disease loci. Results from three methods for estimating local
variance-components are reported, h2g (standard), h
2
gLD (LD-
residual adjusted), and h2gLDAK (LDAK adjusted). Gain column
reports corresponding h2g=h
2
null, where h
2
null is computed based on
the genome-wide h2g and locus size. P-value computed from z-test
using analytical standard error.
(PDF)
Table S21 Heritability of autoimmune disease loci adjusted for
genic enrichment. Enrichment of GWAS loci at genic regions is
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quantified and adjusted for by recomputing h2null as weighted
average of genic and non-genic region size and corresponding total
genome-wide h2gLD. Total h
2
gLD computed from two variance-
components for genic and non-genic regions modeled jointly. P-
value computed for h2gLD versus adjusted h
2
null using analytical
standard error.
(PDF)
Table S22 Combined local heritability for autoimmune traits.
Estimates of local heritability from known GWAS loci for the
respective trait and any known loci for other autoimmune traits
are presented separately and together. h2GWAS reports the
heritability at known GWAS loci for the specified trait. h2GWAS
for non-trait autoimmune loci is zero by definition. h2null is
computed from h2GWAS and genome-wide h
2
g. P-values are
computed by z-test using the analytical standard error on h2gLD.
(PDF)
Table S23 Fraction of local heritability explained in RACI
simulated phenotypes. Analysis of simulated disease architecture
with 180 causal 1 Mbp loci yielding a true h2~0:1. In each locus,
1–10 causal variants were sampled from either low-frequency
(0:01vMAFv0:05) of common (MAFw0:10) ImmunoChip
SNPs and then hidden. For each of four methods tested, the
fraction of local heritability identified by the method is reported
over 30 simulations (with standard error in parenthesis). h2GWAS
was restricted to SNPs present in WTCCC1 only (consistent with
our real analysis). The gain of h2gLD over h
2
GWAS is reported in the
bottom row of each panel.
(PDF)
Table S24 Computation of increased heritability in Immuno-
Chip data. Four alternative estimates of h2null are considered for the
ImmunoChip data. Top two panels show enrichment assuming h2g
total equals 0.17 as in WTCCC1 or 0.40 as in previously published
estimates of h2. Bottom two panels show the same two assumptions
with ‘‘flanking’’ regions estimated from tagging in 1,000 Genomes
(see Results). P-value computed for h2gLD versus corresponding
h2null using analytical standard error.
(PDF)
Table S25 Heritability of previously implicated RA loci in
ImmunoChip. Components of local heritability were estimated at
two groups of loci suspected in previously published papers. P-
value computed for h2gLD versus corresponding h
2
null using
analytical standard error.
(PDF)
Table S26 SNPs analyzed in local variance-components. The
number and allele frequency spectrum of SNPs used in local
heritability analysis. For known GWAS loci, all genotyped SNPs at
the locus as well as any imputed GWAS associated SNPs were
included (over the seven WTCCC1 where imputation was
performed). For autoimmune loci only genotyped SNPs were
included. Effective number of SNPs computed as the sum of SNP
variances after performing the LD residual.
(PDF)
Table S27 Local heritability enrichment adjusted for SNP
density and SNP LD. Three metrics of local expectation are
considered: ‘‘Physical size’’: the fraction of the physical genome
taken up by the loci; ‘‘SNP size’’: the fraction of SNPs within the
loci; ‘‘LD residual variance’’: the fraction of SNP variances in the
loci after transforming to LD residuals. For each metric, the local
expectation is recomputed and the resulting ‘‘Gain’’ (h2gLD=h
2
null) is
reported with its corresponding p-value.
(PDF)
Table S28 Heritability of MS data with PCA-matched samples.
Cases and controls were matched pair-wise based on top 20
principal components (retaining 8,149 samples) and components
of local heritability re-estimate.
(PDF)
Table S29 Fraction of local heritability observed in simulation
(frequency-normalized allelic effect sizes, imputed SNPs tested).
Trait simulated and tested as in Table S10 without hiding causal
variants. Reported h2 values correspond to the fraction of total
heritability (0.02) observed by each corresponding method,
averaged over 50 trails with standard error in parenthesis. Gain
columns report the ratio of corresponding h2 to h2GWAS, with bold-
face indicating significant differences by t-test (Pv0:05). P(h2gLD
vs. h2gLDAK) column reports P-value for difference between h
2
gLD
and h2gLDAK results by Welch’s t-test.
(PDF)
Table S30 Fraction of local heritability observed in simulation
(normal allelic effect sizes, imputed SNPs tested). Trait simulated
and tested as in Table S11 without hiding causal variants.
Reported h2 values correspond to the fraction of total heritability
(0.02) observed by each corresponding method, averaged over 50
trails with standard error in parenthesis. Gain columns report the
ratio of corresponding h2 to h2GWAS, with bold-face indicating
significant differences by t-test (Pv0:05). P(h2gLD vs. h2gLDAK)
column reports P-value for difference between h2gLD and h
2
gLDAK
results by Welch’s t-test.
(PDF)
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